StockpollyBeta
Get App
Popularity #2,474
SENS · NASDAQ · Medical - Devices

Senseonics (SENS)

Develops implantable Eversense systems for long-term glucose monitoring in adults with diabetes.

$9.97
After hours−0.08 (−0.80%)
At close$10.05(+2.76%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue685548678141214
Cost of revenue575584545756
Gross profit1100−44233879
201819201918151723293945
Research & development131110111197889912
Selling, general & administrative77898981015203033
Operating income−19−17−18−19−23−14−13−14−20−21−32−36
−50−1−1−1−1−10000−1
Interest income111111111111
Interest expense222222111112
Other non-operating income3−2−1−1−1−1−1−1−1−1−1−1
Income before tax−24−17−19−20−24−15−14−15−20−21−32−37
Net income from continuing operations−24−17−19−20−24−15−14−15−20−21−32−37
Net income−24−17−19−20−24−15−14−15−20−21−32−37
EPS, basic−$0.81−$0.65−$0.61−$0.66−$0.77−$0.46−$0.40−$0.52−$0.43−$0.50−$0.71−$0.63
EPS, diluted−$0.81−$0.65−$0.61−$0.66−$0.77−$0.46−$0.40−$0.52−$0.43−$0.50−$0.71−$0.63
Weighted average shares, basic302731313133363045424658
Weighted average shares, diluted302731313133363045424658
EBITDA−21−15−17−18−22−13−12−13−18−19−31−35
Depreciation & amortization010001000011
EBIT−22−15−17−18−22−13−13−13−18−20−31−35